These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20887575)

  • 1. Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders.
    Baillie AJ; Stapinski L; Crome E; Morley K; Sannibale C; Haber P; Teesson M
    Drug Alcohol Rev; 2010 Sep; 29(5):518-24. PubMed ID: 20887575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.
    Hall W; Degenhardt L; Teesson M
    Addict Behav; 2009; 34(6-7):526-30. PubMed ID: 19386422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding and treating comorbid anxiety disorders in substance users: review and future directions.
    Wolitzky-Taylor K; Operskalski JT; Ries R; Craske MG; Roy-Byrne P
    J Addict Med; 2011 Dec; 5(4):233-47. PubMed ID: 22042216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepines and the treatment of anxiety disorders in patients with comorbid alcohol and/or drug abuse.
    Sher L
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170-1. PubMed ID: 18354817
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychiatric aspects of comorbid HIV/AIDS and pain, Part 2.
    Douaihy AB; Stowell KR; Kohnen S; Stoklosa JB; Breitbart WS
    AIDS Read; 2007 Jul; 17(7):350-2, 357-61. PubMed ID: 17672014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: results of an international task force.
    Merikangas KR; Angst J; Eaton W; Canino G; Rubio-Stipec M; Wacker H; Wittchen HU; Andrade L; Essau C; Whitaker A; Kraemer H; Robins LN; Kupfer DJ
    Br J Psychiatry Suppl; 1996 Jun; (30):58-67. PubMed ID: 8864150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders.
    Bizzarri JV; Rucci P; Sbrana A; Gonnelli C; Massei GJ; Ravani L; Girelli M; Dell'osso L; Cassano GB
    Addict Behav; 2007 Feb; 32(2):384-91. PubMed ID: 16797139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety and addiction: a clinical perspective on comorbidity.
    DuPont RL
    Bull Menninger Clin; 1995; 59(2 Suppl A):A53-72. PubMed ID: 7795572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for patients with dual diagnosis: a review.
    Tiet QQ; Mausbach B
    Alcohol Clin Exp Res; 2007 Apr; 31(4):513-36. PubMed ID: 17374031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical challenges in the treatment of patients with posttraumatic stress disorder and substance abuse.
    Schäfer I; Najavits LM
    Curr Opin Psychiatry; 2007 Nov; 20(6):614-8. PubMed ID: 17921765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders.
    Van den Brink W; Montgomery SA; Van Ree JM; van Zwieten-Boot BJ;
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):224-30. PubMed ID: 16442270
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence, recognition, and treatment of comorbid depression and anxiety.
    Rapaport MH
    J Clin Psychiatry; 2001; 62 Suppl 24():6-10. PubMed ID: 11676431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric comorbidity in older adults with bipolar disorder.
    Sajatovic M; Blow FC; Ignacio RV
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):582-7. PubMed ID: 16783798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New methodological directions for psychological intervention research among substance users.
    Baker AL
    Drug Alcohol Rev; 2010 Sep; 29(5):467-8. PubMed ID: 20887568
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes.
    Ouimette PC; Gima K; Moos RH; Finney JW
    Alcohol Clin Exp Res; 1999 Mar; 23(3):552-7. PubMed ID: 10195832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.